Ingersoll Rand (IR) Q1 2026 Earnings
Reported Apr 28, 2026 at 4:19 PM ET · SEC Source
Q1 26 EPS
$0.77
BEAT +4.03%
Est. $0.74
Q1 26 Revenue
$1.85B
BEAT +0.92%
Est. $1.83B
vs S&P Since Q1 26
-3.3%
TRAILING MARKET
IR +1.5% vs S&P +4.8%
Market Reaction
Did IR Beat Earnings? Q1 2026 Results
Ingersoll Rand opened 2026 with a quarter that cleared Wall Street's bar on both top and bottom lines, posting adjusted diluted EPS of $0.77 against a consensus of $0.74, a beat of 4.03%, while revenue of $1.85 billion edged past estimates by 0.92% a… Read more Ingersoll Rand opened 2026 with a quarter that cleared Wall Street's bar on both top and bottom lines, posting adjusted diluted EPS of $0.77 against a consensus of $0.74, a beat of 4.03%, while revenue of $1.85 billion edged past estimates by 0.92% and grew 7.6% year over year. The headline growth was powered largely by acquisitions and favorable foreign currency, though organic revenue slipped 0.3%, a dynamic that also weighed on the Industrial Technologies and Services segment, where adjusted EBITDA margin compressed 210 basis points to 26.7%. The brighter spot was Precision and Science Technologies, which delivered 4% organic revenue growth and margin expansion of 120 basis points to 30.3%. Despite the solid beat, the stock has come under pressure, trading near a 52-week low as investors weigh tariff-related headwinds against management's steady full-year outlook, which calls for revenue growth of 2.5% to 4.5% and adjusted EPS of $3.45 to $3.57, representing approximately 5% growth at the midpoint.
Key Takeaways
- • Ingersoll Rand Execution Excellence (IRX) methodology driving operational discipline
- • Acquisitions contributed 3.7% to reported revenue growth
- • Foreign currency contributed 4.2% to reported revenue growth
- • P&ST segment organic revenue growth of 4% with 120 bps margin expansion
- • Tariff pricing offset tariff costs one-for-one in IT&S
- • IT&S book-to-bill ratio of 1.08x
IR Forward Guidance & Outlook
Ingersoll Rand is maintaining its full-year 2026 guidance: revenue growth of 2.5% to 4.5% (organic growth flat to 2%, ~2% from M&A, ~0.5% currency), Adjusted EBITDA of $2,130M to $2,190M, Adjusted EPS of $3.45 to $3.57 (+5% growth at midpoint), and free cash flow to adjusted net income conversion of ~95%. Revenue phasing is expected at 48% first half / 52% second half. The company does not expect significant impact from Section 232 tariff changes or the Middle East conflict on full-year guidance. Key assumptions include ~$170M corporate costs, ~$230M net interest expense, ~23% adjusted tax rate, ~394M share count, and CAPEX at ~2% of sales.
IR YoY Financials
Q1 2026 vs Q1 2025, source: SEC Filings
IR Revenue by Segment
With YoY comparisons, source: SEC Filings
“We began 2026 with solid momentum, delivering high single-digit Adjusted EPS growth and meeting our expectations for Revenue and Adjusted EBITDA. With a robust M&A pipeline, we remain confident in reaching our annual revenue target. Our Economic Growth Engine, IRX, and ownership mindset will continue to support disciplined execution and durable value creation.”
— Vicente Reynal, Q1 2026 Earnings Press Release
IR Earnings Trends
IR vs Market 30 Day Price Reactions
30-day stock return vs benchmark after each earnings
IR EPS Trend
Earnings per share: estimate vs actual
IR Revenue Trend
Quarterly revenue: estimate vs actual
IR Quarterly Results
4 quarters of earnings data
| Quarter | EPS Est. | EPS Act. | Surprise | Revenue | Rev. Surprise |
|---|---|---|---|---|---|
| Q1 26 BEAT | $0.74 | $0.77 | +4.03% | $1.85B | +0.92% |
| Q4 25 BEAT FY | $0.90 | $0.96 | +6.57% | $2.09B | +2.58% |
| FY Full Year | — | $3.34 | — | $7.65B | — |
| Q3 25 MISS | $0.86 | $0.86 | -0.30% | $1.96B | +0.36% |
| Q2 25 BEAT | $0.80 | $0.80 | +0.40% | $1.89B | +2.21% |